Wound healing and body recovery after minimally invasive surgery
Conditions
Interventions
Experimental group:Zeng jian Oral Liquid + Ling zhi huang Capsules
Control Group 1:Zeng jian Oral Liquid + Ling zhi huang Placebo
Control Group 2:Zeng jian Placebo + Lingzhi Huang Capsules
Sponsors
Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: Age: 35 to 75 years old, gender not limited 2: Voluntarily participate, sign a written informed consent form, and cooperate with the clinical trial 3: Patients after minimally invasive surgery in general surgery (excluding drainage ports)
Exclusion criteria
Exclusion criteria: 1: Those who are allergic to multiple drugs or the known components of the product under study 2: Pregnant or lactating women 3: Those with severe heart, brain, liver, kidney, hematopoietic system diseases and mental illness 4: Those with concurrent autoimmune diseases such as malignant tumors and systemic lupus erythematosus 5: Those who take the medicine frequently or have participated in other clinical trials within the past 4 weeks 6: Situations where other researchers consider it inappropriate to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Symptom Score Scale;Postoperative wound evaluation indicators;Overall Assessment of Health Status (SF36 Scale); | — |
Secondary
| Measure | Time frame |
|---|---|
| Seven immune items (Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Immunoglobulin E, Complement component 3, Complement component 4, total complement);Inflammatory indicators (C-Reactive Protein, Interleukin-6);Physical nutritional indicators (serum albumin);Postoperative wound pain degree (VAS Scale);Sleep Assessment Scale;Tissue oxygenation status; | — |
Countries
China
Contacts
Public ContactYao Jiamei
Xiangya Hospital, Central South University
Outcome results
None listed